| http://www.w3.org/ns/prov#value | - While we tend to think of all protease inhibitors and thymidine analogue (TA) nucleoside reverse transcriptase inhibitors (NRTIs) as lipid unfavorable, and non-nucleoside reverse transcriptase inhibitors (NNRTIs) and non-TA NRTIs as lipid favorable, studies such as 2NN and D:A:D have shown that differences exist between medications even within the same class.
|
